It is known to be frequently altered in human cancers, especially in breast cancer [5], with its overexpression associated with the activation of oncogenes such as PIK3CA and MTOR and inactivation of tumor suppressor genes such as PIK3R1 and PTEN [6]. Here, PIK3CA is linked to breast carcinoma.